arthritis News
-
Showcase
10 Years of Peer-Reviewed Studies Predicting and Informing the Prognosis Profile of Autoimmune Patients
Recent journal publications are fortifying the clinically important role of the 14-3-3η blood test along the whole continuum of RA and autoimmune patient care. From RA meta-analysis data through to 14-3-3η expression in juvenile idiopathic arthritis and secondary Sjögren’s syndrome in Lupus, the importance of this protein across a spectrum of autoimmune conditions is ...
-
Amgen And Lance Bass Partner To Encourage People To Do A `Double Take` To Recognize The Early Signs Of Psoriatic Arthritis
THOUSAND OAKS, Calif., May 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with pop icon and entrepreneur Lance Bass, for the Double Take campaign to empower people to take action when it comes to psoriatic arthritis. As a singer, dancer and entertainer, Bass understands the importance of staying in tune with your body. Through the campaign, he has created ...
By Amgen Inc.
-
DT MedTech Announces 510(k) FDA Clearance for Hintermann Series H2 Total Ankle Replacement System
DT MedTech, LLC (DTM) today announced that the Hintermann Series H2 Total Ankle Replacement System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The Hintermann Series H2 is a semi-constrained, total ankle replacement prosthesis developed by Prof. Beat Hintermann, a world-renowned foot and ankle surgeon based in Liestal, Switzerland. The Hintermann Series H2 ...
-
KT Connects (Webinar Series) Returns January 31 – Register Now!
KT Connects, a series of beginner-level training webinars for researchers and trainees, returns to the airwaves in 2020. Kicking off the new year will be Karine Souffez, associate director of knowledge exchange at UBC. Karine will present the exciting work of UBC’s new Knowledge Exchange (Kx) Unit and how they are working to engage the academic community. She will discuss some of the ...
-
USPTO Awards Another Patent; New Data Demonstrating 14-3-3? as a Biomarker for Monitoring Therapy Response
USPTO Awards Patent for Citrullinated 14-3-3: Expanding Augurex’s Portfolio in the Diagnosis of Rheumatoid Arthritis (RA) On November 20th, 2018 the US Patent and Trademark Office (USPTO) awarded patent number 10,132,806 entitled “Antigens Derived From Citrullinated 14-3-3 And Uses Thereof In The Diagnosis of Rheumatoid Arthritis.” Citrullinated 14-3-3η auto-antibodies are ...
-
January teleconferences enable business and nonprofit execs to up their cause marketing knowledge
The Cause Marketing Forum is proud to kick off 2011 with a pair outstanding distance learning programs: “The Cause Marketing 101 Series” beginning January 19 and “Breakthrough Nonprofit Branding” featuring Carol Cone on January 25. Cause Marketing 101 If you’re a business or nonprofit professional who wants a solid grounding in cause marketing strategy and tactics, ...
By 3BL Media
-
Using fungi to slow down cellular ageing
Founded in 2014, KiOmed Pharma is a spin-off of KitoZyme. As explained by François Blondel, Founder and Executive Chairman of the Board of Directors, and Houtai Choumane, CEO of KiOmed Pharma, its aim is to offer solutions to cellular ageing using innovation based on mushrooms. How does your innovation provide a solution for the healthcare sector? François Blondel: ‘We work ...
-
Panag Pharma Inc. Announces Initiation Of A Clinical Trial
Halifax, Nova Scotia. Panag Pharma, Inc. launched a clinical trial evaluating the use of the newly NHP registered product Topical AOTC, a new generation topical for pain and pain associated with inflammation. Topical AOTC is a Health Canada approved natural health product indicated for temporary relief of aches and pains of muscles and joints associated with simple backache, lumbago, ...
-
Biopticon Reaches Milestone in Market Adoption
Biopticon Corporation reaches milestone in market adoption of their innovative Tumor Management System for preclinical oncology studies. Innovative instrument and software create revolutionary system to improve data, work-flow and results from in vivo cancer models Princeton, NJ Biopticon today announced that it had met its first milestone for customer adoption of the revolutionary ...
-
Amgen And Lance Bass Partner To Encourage People To Do A `Double Take` To Recognize The Early Signs Of Psoriatic Arthritis
THOUSAND OAKS, Calif., May 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with pop icon and entrepreneur Lance Bass, for the Double Take campaign to empower people to take action when it comes to psoriatic arthritis. As a singer, dancer and entertainer, Bass understands the importance of staying in tune with your body. Through the campaign, he has created ...
By Amgen Inc.
-
Panag Pharma Announces Health Canada License for Topical A OTC (NPN 80070485)
Panag Pharma announces Health Canada approval for Topical AOTC, a new generation topical formulation with a dual mechanism of action against pain. Topical AOTC is a natural health product indicated for temporarily relief of aches and pains of muscles and joints associated with simple backache, lumbago, strains and sprains and arthritis. Topical AOTC uses a novel technology targeting the ...
-
Aurobindo Pharma receives USFDA Approval for Ibuprofen OTC Capsules
Aurobindo Pharma Limited is pleased to announce that the Company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Ibuprofen capsules OTC, 200mg. Aurobindo’s Ibuprofen capsules are a generic equivalent of Pfizer’s Advil Liqui-Gels Capsules. The product will be launched in Sep 2018. Ibuprofen is used to relieve pain from various conditions ...
-
Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced the outcome of the U.S. Food and Drug Administration (FDA) Joint Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee on tanezumab. There was a single voting question focused on whether the proposed risk evaluation and mitigation strategy (REMS) for tanezumab will ensure its benefits ...
-
National Psoriasis Awareness Month: Grace`s Story
August is National Psoriasis Awareness Month. To bring awareness to the illness and injection challenges, we spoke with Grace Vasher and learned about her personal journey with Psoriasis. Grace is a nineteen year old college student studying elementary education. “Psoriasis is something I have experienced from a very young age. I was officially diagnosed with Psoriasis ...
-
Setpoint Medical announces oral presentation of results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results from its U.S. pilot Investigational Device Exemption (IDE) study in rheumatoid arthritis (RA) have been accepted for oral presentation at the American College of Rheumatology (ACR) Annual Meeting, being held November 8-13, 2019 in Atlanta, GA. The ...
-
LISCure Biosciences received clinical approval for two microbiome programs targeting autoimmune disease and NASH
LISCure Biosciences ("LISCure") announced that it has received approval for a global phase 1 clinical trial for two programs, LB-P6 and LB-P8, targeting autoimmune disease and non-alcoholic steatohepatitis (NASH), respectively. This achievement is significant in that it will be the first global clinical trial among the microbiome treatments for rheumatoid arthritis and NASH indications. The most ...
-
Augurex and Quidel at ACR
Augurex and Quidel are pleased to announce the launch of the JOINTstat® 14-3-3η RUO (research use only) ELISA. This new distribution arrangement will get 14-3-3η testing into the hands of more investigators worldwide, including key opinion leaders and pharmaceutical companies, to advance and grow the body of data for this novel joint damage biomarker in autoimmune diseases. There is ...
-
DT MedTech Announces Successful Total Ankle Revision Procedures Using The New Hintermann Series H2 Tibial Assembly Component and PE Inlay
DT MedTech, LLC (DTM) announced today that their new Hintermann Series H2 Tibial Assembly component and PE inlay have been successfully implanted by Prof. Beat Hintermann in three patients needing total ankle revision surgery. World-renowned foot and ankle surgeon, Prof. Hintermann, developed the new, versatile, two-component, semi-constrained total ankle replacement prosthesis, Hintermann Series ...
-
Panag Pharma Announces Launch Of A Regional Pilot Program
Halifax, Nova Scotia. Panag Pharma hosted a seminar for Health Care Professionals and the launch of a Regional Pilot Program to introduce Topical AOTC, a new generation pain and inflammation product. Topical AOTC is a Health Canada approved natural product indicated for temporarily relief of aches and pains of muscles and joints associated with simple backache, lumbago, strains and sprains and ...
-
What Are D-Glucosamines?
Glucosamine is a natural component of cartilage and is widely used as an over-the-counter nutritional supplement to reduce the pain and cartilage loss of osteoarthritis. Glucosamine is usually taken in combination with chondroitin, which is a glycosaminoglycan that also exists in cartilage.Glucosamine is an amino sugar and an important molecule in the biochemical pathway of glycosylated protein ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you